|
1.
|
Hurtgen BJ, Hung CY, Ostroff GR, Levitz SM, Cole GT. Construction and Evaluation of a Novel Recombinant T Cell Epitope-Based Vaccine against Coccidioidomycosis. Infect Immun. 2012 Nov; 80(11):3960-74.
|
|
|
|
|
2.
|
Huang H, Ostroff GR, Lee CK, Agarwal S, Ram S, Rice PA, Specht CA, Levitz SM. Relative Contributions of Dectin-1 and Complement to Immune Responses to Particulate ß-Glucans. J Immunol. 2012 May 30.
|
|
|
|
|
3.
|
Soto ER, Caras AC, Kut LC, Castle MK, Ostroff GR. Glucan particles for macrophage targeted delivery of nanoparticles. J Drug Deliv. 2012; 2012:143524.
|
|
|
|
|
4.
|
Agarwal S, Specht CA, Haibin H, Ostroff GR, Ram S, Rice PA, Levitz SM. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. MBio. 2011; 2(5).
|
|
|
|
|
5.
|
Tesz GJ, Aouadi M, Prot M, Nicoloro SM, Boutet E, Amano SU, Goller A, Wang M, Guo CA, Salomon WE, Virbasius JV, Baum RA, O'Connor MJ, Soto E, Ostroff GR, Czech MP. Glucan particles for selective delivery of siRNA to phagocytic cells in mice. Biochem J. 2011 Jun 1; 436(2):351-62.
|
|
|
|
|
6.
|
Huang H, Ostroff GR, Lee CK, Specht CA, Levitz SM. Robust Stimulation of Humoral and Cellular Immune Responses following Vaccination with Antigen-Loaded beta-Glucan Particles. MBio. 2010; 1(3).
|
|
|
|
|
7.
|
Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature. 2009 Apr 30; 458(7242):1180-4.
|
|
|
|
|
8.
|
Huang H, Ostroff GR, Lee CK, Wang JP, Specht CA, Levitz SM. Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists. Infect Immun. 2009 May; 77(5):1774-81.
|
|
|
|
|
9.
|
Soto ER, Ostroff GR. Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery. Bioconjug Chem. 2008 Apr; 19(4):840-8.
|
|
|
|
|
10.
|
Young SH, Ostroff GR, Zeidler-Erdely PC, Roberts JR, Antonini JM, Castranova V. A comparison of the pulmonary inflammatory potential of different components of yeast cell wall. J Toxicol Environ Health A. 2007 Jul; 70(13):1116-24.
|
|
|
|
|
11.
|
Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004 Jul 15; 173(2):797-806.
|
|
|
|
|
12.
|
Hong F, Hansen RD, Yan J, Allendorf DJ, Baran JT, Ostroff GR, Ross GD. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells. Cancer Res. 2003 Dec 15; 63(24):9023-31.
|
|
|
|
|
13.
|
Donzelli BG, Ostroff G, Harman GE. Enhanced enzymatic hydrolysis of langostino shell chitin with mixtures of enzymes from bacterial and fungal sources. Carbohydr Res. 2003 Sep 1; 338(18):1823-33.
|
|
|
|
|
14.
|
Kournikakis B, Mandeville R, Brousseau P, Ostroff G. Anthrax-protective effects of yeast beta 1,3 glucans. MedGenMed. 2003 Mar 21; 5(1):1.
|
|
|
|
|
15.
|
Niederman R, Kelderman H, Socransky S, Ostroff G, Genco C, Kent R, Stashenko P. Enhanced neutrophil emigration and Porphyromonas gingivalis reduction following PGG-glucan treatment of mice. Arch Oral Biol. 2002 Aug; 47(8):613-8.
|
|
|
|
|
16.
|
Bell S, Goldman VM, Bistrian BR, Arnold AH, Ostroff G, Forse RA. Effect of beta-glucan from oats and yeast on serum lipids. Crit Rev Food Sci Nutr. 1999 Mar; 39(2):189-202.
|
|
|
|
|
17.
|
Stashenko P, Wang CY, Riley E, Wu Y, Ostroff G, Niederman R. Reduction of infection-stimulated periapical bone resorption by the biological response modifier PGG glucan. J Dent Res. 1995 Jan; 74(1):323-30.
|
|
|
|
|
18.
|
Onderdonk AB, Cisneros RL, Hinkson P, Ostroff G. Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo. Infect Immun. 1992 Apr; 60(4):1642-7.
|
|
|
|
|
19.
|
Simon ES, Toone EJ, Ostroff G, Bednarski MD, Whitesides GM. Preparation of cytidine 5'-monophospho-N-acetylneuraminic acid and uridine 5'-diphosphoglucuronic acid; syntheses of alpha-2, 6-sialyllactosamine, alpha-2, 6-sialyllactose, and hyaluronic acid. Methods Enzymol. 1989; 179:275-87.
|
|
|
|
|
20.
|
Ostroff GR, Pène JJ. Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis. I. Construction and analysis of B. subtilis clone banks in Escherichia coli. Mol Gen Genet. 1984; 193(2):299-305.
|
|
|
|
|
21.
|
Ostroff GR, Pène JJ. Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis. II. Transfer of sequences propagated in Escherichia coli to B. subtilis. Mol Gen Genet. 1984; 193(2):306-11.
|
|
|
|
|
22.
|
Ostroff GR, Pène JJ. Molecular cloning with bifunctional plasmid vectors in Bacillus subtilis: isolation of a spontaneous mutant of Bacillus subtilis with enhanced transformability for Escherichia coli-propagated chimeric plasmid DNA. J Bacteriol. 1983 Nov; 156(2):934-6.
|
|
|
|
|
23.
|
Lynfield YL, Ostroff G. Psoriatic flora. Arch Dermatol. 1973 Sep; 108(3):424-5.
|
|
|
|
|
24.
|
Lynfield YL, Ostroff G, Abraham J. Bacteria, skin sterilization, and wound healing in psoriasis. N Y State J Med. 1972 Jun 1; 72(11):1247-50.
|
|
|
|
|
25.
|
ALLEN EG, OSTROFF G, BOVARNICK MR. Inhibition of the cytochrome reductase activity associated with menigopneumonitis virus by fatty acids derived from infected allantoic fluids. Virology. 1960 Aug; 11:737-52.
|
|
|
|
|
26.
|
LEVEEN HH, FALK G, OSTROFF G, CALEM WS. The production of ulcerative colitis by anticolon sera. Surg Forum. 1960; 11:3-5.
|
|
|
|
|
27.
|
OSTROFF G, AXELROD DR, BOVARNICK M. Antigenicity of polymers of glutamyl peptide on humans. Proc Soc Exp Biol Med. 1958 Nov; 99(2):345-7.
|
|
|
|
|
28.
|
SCHIER WW, ROTH A, OSTROFF G, SCHRIFT MH. Hodgkin's disease and immunity. Am J Med. 1956 Jan; 20(1):94-9.
|
|
|
|
